Suppr超能文献

使用可逆慢解离速率探针定量测定ERK1/2抑制剂的细胞靶点占有率

Quantitation of ERK1/2 inhibitor cellular target occupancies with a reversible slow off-rate probe.

作者信息

Lebraud Honorine, Surova Olga, Courtin Aurélie, O'Reilly Marc, Valenzano Chiara R, Nordlund Pär, Heightman Tom D

机构信息

Astex Pharmaceuticals , 436 Cambridge Science Park , Cambridge , CB4 0QA , UK . Email:

Department of Oncology-Pathology , Karolinska Institute , CCK R8:01 , Karolinska Hospital , 171 76 Stockholm , Sweden.

出版信息

Chem Sci. 2018 Sep 17;9(45):8608-8618. doi: 10.1039/c8sc02754d. eCollection 2018 Dec 7.

Abstract

Target engagement is a key concept in drug discovery and its direct measurement can provide a quantitative understanding of drug efficacy and/or toxicity. Failure to demonstrate target occupancy in relevant cells and tissues has been recognised as a contributing factor to the low success rate of clinical drug development. Several techniques are emerging to quantify target engagement in cells; however, measurements remain challenging, mainly due to technical limitations. Here, we report the development of a non-covalent clickable probe, based on SCH772984, a slow off-rate ERK1/2 inhibitor, which enabled efficient pull down of ERK1/2 protein click reaction with tetrazine tagged agarose beads. This was used in a competition setting to measure relative target occupancy by selected ERK1/2 inhibitors. As a reference we used the cellular thermal shift assay, a label-free biophysical assay relying solely on ligand-induced thermodynamic stabilization of proteins. To validate the EC values measured by both methods, the results were compared with IC data for the phosphorylation of RSK, a downstream substrate of ERK1/2 used as a functional biomarker of ERK1/2 inhibition. We showed that a slow off-rate reversible probe can be used to efficiently pull down cellular proteins, significantly extending the potential of the approach beyond the need for covalent or photoaffinity warheads.

摘要

靶点结合是药物研发中的一个关键概念,对其进行直接测量能够提供对药物疗效和/或毒性的定量理解。未能在相关细胞和组织中证明靶点占有率已被认为是临床药物开发成功率低的一个促成因素。有几种技术正在兴起,用于量化细胞中的靶点结合;然而,测量仍然具有挑战性,主要是由于技术限制。在此,我们报告了一种基于SCH772984(一种解离速率慢的ERK1/2抑制剂)的非共价可点击探针的开发,该探针能够通过与四嗪标记的琼脂糖珠进行点击反应,有效地沉淀ERK1/2蛋白。这被用于竞争实验中,以测量所选ERK1/2抑制剂的相对靶点占有率。作为参考,我们使用了细胞热位移分析,这是一种无标记的生物物理分析方法,仅依赖于配体诱导的蛋白质热力学稳定性。为了验证两种方法测得的EC值,将结果与作为ERK1/2抑制功能生物标志物的ERK1/2下游底物RSK磷酸化的IC数据进行了比较。我们表明,一种解离速率慢的可逆探针可用于有效地沉淀细胞蛋白,大大扩展了该方法的潜力,使其不再需要共价或光亲和弹头。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f587/6253716/4860df4a6020/c8sc02754d-f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验